Vantive Health

Today, we announced an agreement to divest the majority of the assets and associated operations related to our hemodialysis (HD) business to @RockwellMedical. 

This transaction marks an important next step in Vantive’s evolution, sharpening our focus on the areas where we believe we can make the greatest impact for patients and care teams.  

Learn more here: vntv.co/48xyXok

#ExpandPossibilities #KidneyCare #Innovation #Healthcare

Critical care is constantly evolving, and advancing care for critically ill patients requires continued collaboration, clinical insight and evidence-driven discussion.

At European Society of Intensive Care Medicine (@ESICM) LIVES 2026 in Lisbon, we recently joined the global intensive care community to exchange expertise, discuss emerging evidence and explore what's shaping the future of critical care.

A highlight of our presence was the Vantive symposium, Personalizing Organ Support Strategies in ICU Patients, chaired by Max Bell and Alexander Zarbock which brought together leading experts to discuss personalized approaches to organ support, blood purification and the latest clinical guidance.

We remain committed to supporting opportunities like this to connect with clinicians and researchers from around the world, exchange expertise and demonstrate how we’re helping support care teams as patient needs evolve.

#ESICM2026 #CriticalCare #ExpandPossibilities

FOR US HEALTHCARE PROFESSIONALS

We're excited to share our plans to expand our integrated HomeAdvantage offering with Avira, a next-generation automated peritoneal dialysis cycler currently under FDA review through the 510(k) process. Avira is not yet FDA cleared and is not available for sale in the U.S.

Attendees at @ASNKidney's Kidney Week got an early look at Avira. HomeAdvantage brings together peritoneal dialysis therapies, services, education and Vantive CONNECT digital solutions throughout the home dialysis experience, all with a vision to make it easier to start, sustain, and ultimately succeed with peritoneal dialysis for both patients and their clinicians.

Avira has received CE marking under the EU Medical Device Regulation, confirming it meets EU regulatory requirements. Avira is not licensed by Health Canada and is not available for sale in Canada. CE marking is separate from Health Canada and FDA reviews and does not affect their processes.

Learn more: vntv.co/48k25ze

#KidneyWk #AccessKidneyCare #ExpandPossibilities #HomeAdvantage

GBU-RC26-260304 (v1.0) 10/2026

For critically ill patients who require continuous renal replacement therapy (CRRT), care delivery can be highly complex. Understanding the operational barriers reported by CRRT experts can help identify opportunities to better support care teams and strengthen therapy delivery.  

At @ASNKidney's Kidney Week, findings were presented from a mixed-methods analysis involving U.S. CRRT experts that explored the clinical and operational factors that can influence how CRRT is used in practice.¹ This is why we’re focused on expanding our kidney care platform to advance a more integrated, simplified approach to treating critically ill patients. Visit booth #749 at #KidneyWk to learn more about our therapies to support critical care teams.

¹Neyra J, et al. “Clinical and Operational Determinants of CRRT Use: A Mixed-Methods Analysis.” Abstract TH-PO0731. Presented at ASN Kidney Week 2026.

#AcuteKidneyInjury #ExpandPossibilities

As the kidney care community gathers at @ASNKidney's Kidney Week to exchange ideas, challenge assumptions and explore what is next for patient care, we’re proud to contribute 13 abstracts spanning chronic and critical care—and to discuss the innovation behind our work with attendees at booth #749.

Together, these touchpoints reflect a shared theme: kidney care is a journey, not a destination. Increasing access to care and improving outcomes requires a coordinated care ecosystem that connects therapies, digital capabilities, education, services and care teams around the needs of patients.

We’re looking forward to learning from the nephrology community and sharing how evidence and innovation can help improve access and strengthen outcomes. If you’re in Denver, we invite you to visit our team on the floor at Kidney Week.

#KidneyWk #AccessKidneyCare #ExpandPossibilities